Claude Maraoui's most recent trade in Journey Medical Corp was a trade of 82,915 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 82,915 | 82,915 | - | - | Stock Option (Right to Buy) | |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 49,277 | 2,397,590 | - | 0 | Common Stock, $0.0001 par value | |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 6.84 per share. | 02 May 2025 | 4,834 | 2,348,313 | - | 6.8 | 33,065 | Common Stock, $0.0001 par value |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 5.01 per share. | 11 Mar 2025 | 49,271 | 2,003,147 | - | 5.0 | 246,848 | Common Stock, $0.0001 par value |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 5.04 per share. | 06 Mar 2025 | 25,551 | 2,067,323 | - | 5.0 | 128,777 | Common Stock, $0.0001 par value |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 5.01 per share. | 06 Mar 2025 | 14,905 | 2,052,418 | - | 5.0 | 74,674 | Common Stock, $0.0001 par value |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 5.04 per share. | 03 Mar 2025 | 28,901 | 2,111,021 | - | 5.0 | 145,661 | Common Stock, $0.0001 par value |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 5.19 per share. | 03 Mar 2025 | 23,508 | 2,139,922 | - | 5.2 | 122,007 | Common Stock, $0.0001 par value |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 5.13 per share. | 03 Mar 2025 | 18,147 | 2,092,874 | - | 5.1 | 93,094 | Common Stock, $0.0001 par value |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.48 per share. | 22 Mar 2024 | 10,000 | 2,163,430 | - | 3.5 | 34,790 | Common Stock, $0.0001 par value |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 175,000 | 2,178,147 | - | 0 | Common Stock, $0.0001 par value | |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 175,000 | 2,353,147 | - | 0 | Common Stock, $0.0001 par value | |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.76 per share. | 24 Jul 2023 | 20,767 | 2,127,386 | - | 1.8 | 36,550 | Common Stock, par value $0.0001 per share |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.34 per share. | 16 May 2023 | 24,377 | 2,148,153 | - | 1.3 | 32,665 | Common Stock, par value $0.0001 per share |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 1.25 per share. | 16 May 2023 | 20,000 | 2,172,530 | - | 1.3 | 25,000 | Common Stock, par value $0.0001 per share |
Journey Medical Corp | Claude Maraoui | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2022 | 300,000 | 2,192,530 | - | 0 | Common Stock, par value $0.0001 per share |